Wilkinson Stekloff Secures Second Decisive Victory for Bayer in Xarelto Trial

NEW ORLEANS, LA – Wilkinson Stekloff won the second bellwether trial on June 12, 2017 in the multi-district litigation over the blood thinner Xarelto. Beth Wilkinson, a founding partner of Wilkinson Stekloff, led the defense to victory on behalf of Bayer and Janssen in the second of four bellwether trials in the MDL. The complete defense verdict came just two hours after closing arguments. This latest victory comes just six weeks after Wilkinson obtained a complete defense verdict in the first bellwether trial in the litigation. The lawsuit alleged that Bayer, and Johnson & Johnson subsidiary Janssen Pharmaceuticals, were liable for claims that the Xarelto label did not adequately instruct doctors on how to minimize the risk of bleeding associated with the anticoagulant Xarelto. In this trial, the plaintiff passed away due to a brain bleed. Wilkinson Stekloff represented Bayer, with Beth Wilkinson serving as lead trial counsel. David Dukes …

Beth Wilkinson Named American Lawyer’s Litigator of the Week and a Law360 Legal Lion for Win in Bellwether Trial for Bayer’s Xarelto

WASHINGTON, May 5, 2017 – Beth Wilkinson was named American Lawyer’s Litigator of the Week and a Law360 Legal Lion. The accolades come after Beth successfully led a team of lawyers in defense of Bayer Healthcare Pharmaceuticals in a key bellwether trial over the blood thinner Xarelto. A federal jury in New Orleans deliberated for about one hour before unanimously deciding in favor of Bayer. On the victory, Wilkinson said, “If you can make your case really clear, so the jury from opening to closings knows what you’re saying, it makes it easier to go back and come to a consensus.” “When doctors come in and say this medication works and is important, it makes it very difficult for plaintiffs to prevail.” Wilkinson will stay on as lead counsel in the next Xarelto trial in New Orleans, scheduled for May 30. Beth Wilkinson is a founding partner at Wilkinson Stekloff. …

Wilkinson Stekloff Wins Bellwether Xarelto Trial For Bayer

Beth Wilkinson, co-founding partner of Wilkinson, Walsh + Eskovitz, led the defense team to victory. WASHINGTON – The Wilkinson, Walsh + Eskovitz trial team led by Founding Partner Beth Wilkinson secured a major victory for Bayer in the first bellwether trial in a multi-district litigation involving the drug Xarelto. The lawsuit alleged that Bayer, and Johnson & Johnson subsidiary Janssen Pharmaceuticals, were liable for claims that the Xarelto label did not adequately instruct doctors on how to minimize the risk of bleeding associated with the anticoagulant Xareltot. The nine-member jury in New Orleans returned a unanimous defense verdict roughly one hour after closing arguments. Wilkinson served as lead counsel on the case and delivered both opening and closing arguments at trial. David Dukes of Nelson Mullins Riley & Scarborough and Richard Sarver of Barrasso Usdin Kupperman Freeman & Sarver also served as trial counsel for Bayer and Janssen, respectively. The …

Benchmark Names Wilkinson Stekloff “Boutique Firm of the Year”

WASHINGTON – Benchmark Litigation named Wilkinson Stekloff the “Boutique Firm of the Year” during its annual awards ceremony in New York City. This prestigious award recognizes Wilkinson Stekloff’s remarkable accomplishments in just its first year, including a high-stakes jury trial win two months after opening its doors last February and other high-profile engagements for the NFL, Pfizer, Facebook, Bayer, the NCAA, Theranos, and Medtronic. “The Benchmark award recognizes our commitment to excellence and getting results for our clients,” said founding partner Beth Wilkinson, an American Lawyer Litigator of the Year. “We have the best trial teams, with unmatched courtroom experience, ready to win more high-stakes cases across the country.” In selecting Wilkinson Stekloff for this award, Benchmark described the trial-focused boutique as “emblematic of a litigator’s dream shop, boasting composite qualities of diversity, youth, and a culture fostering a work-hard-play-hard ethos that its personnel takes to heart.” With offices in …